We propose to establish a National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine, Nashville, TN. The Resource would focus on technology advances and innovation that generally would include next generation hardware, software and methods relevant to direct tissue profiling and imaging using mass spectrometry. At the same time, a number of applications in the biological and medical area that would derive significant benefits from this developing technology will be undertaken. In turn, the technical needs of these biological investigations will feed back and help focus and drive additional technology improvement and innovation. The technology program proposed here would involve significant development of histology directed mass spectrometric profiling and imaging of tissues, a new ion source geometry for transmission geometry laser illumination of tissues for single cell analysis, high spatial resolution imaging down to one micron lateral resolution, high sensitivity profiling and imaging to measure lower abundance species than is now possible, and the development of the relevant biocomputational resources to complement the technological advances and enable it to be routinely used by biologists and medical research investigators who are not experts in the field of the technology. The driving biology would be focused on applications that would require new capabilities, such as high spatial resolution imaging of the serotonin neuron proteome in neurodevelopmental disorders, studies of breast and prostate cancer, age related macular degeneration, selected stem cell analyses, studies of the glomerulus in diabetic nephropathy, molecular presentations in malformed heart valve development, and aspects of tumor angiogenesis and growth. Important activities of the Resource would also involve selected collaborations of NIH sponsored research that would significantly benefit from the developing technology of Imaging Mass Spectrometry, to offer core capabilities that include secondary ion mass spectrometry for ultra high resolution imaging of low MW species, and FT ICR instrumentation and expertise for ultra high mass spectrometric resolution Training and dissemination of the technology as well as the expertise present in the Resource would be accomplished through a yearly short course, individual scientific visits by established scientists and trainees, and publication of the outcomes of both the technology and applications programs.

Public Health Relevance

The Resource is involved the discovery of molecular events that occur in disease using advanced instrumentation that is able to measure minute amounts of material. The Resource includes the development of 'next generation'technologies to make higher sensitivity and higher resolution measurements on tissues than can be done currently and apply these technologies to specific biological projects to study specific diseases, such as cancer, kidney disease, diabetes, and neurological disorders. The outcome of this work will be a new understanding of the biology of health and disease that will lead to new treatment opportunities for patients with these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Biotechnology Resource Grants (P41)
Project #
5P41GM103391-04
Application #
8601190
Study Section
Special Emphasis Panel (ZRG1-BCMB-N (40))
Program Officer
Sheeley, Douglas
Project Start
2011-02-15
Project End
2015-12-31
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
4
Fiscal Year
2014
Total Cost
$1,627,753
Indirect Cost
$559,993
Name
Vanderbilt University Medical Center
Department
Biochemistry
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Nye-Wood, Mitchell G; Spraggins, Jeffrey M; Caprioli, Richard M et al. (2017) Spatial distributions of glutathione and its endogenous conjugates in normal bovine lens and a model of lens aging. Exp Eye Res 154:70-78
Lazova, Rossitza; Yang, Zhe; El Habr, Constantin et al. (2017) Mass Spectrometry Imaging Can Distinguish on a Proteomic Level Between Proliferative Nodules Within a Benign Congenital Nevus and Malignant Melanoma. Am J Dermatopathol 39:689-695
Prentice, Boone M; Chumbley, Chad W; Caprioli, Richard M (2017) Absolute Quantification of Rifampicin by MALDI Imaging Mass Spectrometry Using Multiple TOF/TOF Events in a Single Laser Shot. J Am Soc Mass Spectrom 28:136-144
Juttukonda, Lillian J; Berends, Evelien T M; Zackular, Joseph P et al. (2017) Dietary Manganese Promotes Staphylococcal Infection of the Heart. Cell Host Microbe 22:531-542.e8
Angel, Peggi M; Baldwin, H Scott; Gottlieb Sen, Danielle et al. (2017) Advances in MALDI imaging mass spectrometry of proteins in cardiac tissue, including the heart valve. Biochim Biophys Acta 1865:927-935
Lagarrigue, Mélanie; Caprioli, Richard M; Pineau, Charles (2016) Potential of MALDI imaging for the toxicological evaluation of environmental pollutants. J Proteomics 144:133-9
Chumbley, Chad W; Reyzer, Michelle L; Allen, Jamie L et al. (2016) Absolute Quantitative MALDI Imaging Mass Spectrometry: A Case of Rifampicin in Liver Tissues. Anal Chem 88:2392-8
Anderson, David M G; Van de Plas, Raf; Rose, Kristie L et al. (2016) 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. J Proteomics 149:77-84
Zubair, Faizan; Laibinis, Paul E; Swisher, William G et al. (2016) Trypsin and MALDI matrix pre-coated targets simplify sample preparation for mapping proteomic distributions within biological tissues by imaging mass spectrometry. J Mass Spectrom 51:1168-1179
Zackular, Joseph P; Moore, Jessica L; Jordan, Ashley T et al. (2016) Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection. Nat Med 22:1330-1334

Showing the most recent 10 out of 72 publications